Willem Flameng
Corporate Officer/Principal bei Katholieke Universiteit Leuven
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Geofrey de Visscher | M | - |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD.
Katholieke Universiteit Leuven
| 23 Jahre |
Herman Daems | M | 78 |
Katholieke Universiteit Leuven
| 12 Jahre |
Koenraad Debackere | M | 63 |
Katholieke Universiteit Leuven
| - |
Pol Bamelis | M | 85 |
Katholieke Universiteit Leuven
| - |
Marleen Willekens | M | 58 |
Katholieke Universiteit Leuven
| 29 Jahre |
Liesbet van der Perre | M | 55 |
Katholieke Universiteit Leuven
| - |
Hilde Laga | M | 68 |
Katholieke Universiteit Leuven
| - |
Giorgio Basevi | M | 85 |
Katholieke Universiteit Leuven
| - |
Jos van der Sloten | M | 61 |
Katholieke Universiteit Leuven
| 18 Jahre |
Koen Geens | M | 66 |
Katholieke Universiteit Leuven
| - |
Jules Stuyck | M | 76 |
Katholieke Universiteit Leuven
| - |
Michiel S. J. Steyaert | M | - |
Katholieke Universiteit Leuven
| - |
Jan Smets | M | 73 |
Katholieke Universiteit Leuven
| - |
Katrien Kesteloot | F | 61 |
Katholieke Universiteit Leuven
| - |
André Oosterlinck | M | 78 |
Katholieke Universiteit Leuven
| - |
Dirk Heremans | M | 81 |
Katholieke Universiteit Leuven
| - |
Cynthia van Hulle | M | 68 |
Katholieke Universiteit Leuven
| - |
Filip Roodhooft | M | - |
Katholieke Universiteit Leuven
| - |
Koen van Gerven | M | 65 |
Katholieke Universiteit Leuven
| - |
Johan Hendrik Neyts | M | - |
Katholieke Universiteit Leuven
| - |
Fred van Leuven | M | - |
Katholieke Universiteit Leuven
| - |
Bart de Moor | M | 63 |
Katholieke Universiteit Leuven
| - |
Luc Jacques Bertrand | M | 73 |
Katholieke Universiteit Leuven
| - |
Bart Boesmans | M | 60 |
Katholieke Universiteit Leuven
| 10 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Els Vanheusden | M | - |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
Frank Bulens | M | 61 |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
Paul van Dun | M | - |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
Jaak Minten | M | - |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
Annie van Broeckhoven | M | - |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Belgien | 29 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Willem Flameng
- Persönliches Netzwerk